Marek Niedoszytko

Hereditary α tryptasemia is a valid genetic biomarker for severe mediator-related symptoms in mastocytosis

Georg Greiner, Bettina Sprinzl, Aleksandra Górska et al. · Blood · 2020 · 184 citations · Full text

Life Sciences, Genetics, Molecular Genetics +16

Proposed diagnostic algorithm for patients with suspected mastocytosis: a proposal of the European Competence Network on Mastocytosis

Peter Valent, Luís Escribano, Sigurd Broesby‐Olsen et al. · Allergy · 2014 · 170 citations · Full text

Medicine, Dermatology, Pathology +15

International prognostic scoring system for mastocytosis (IPSM): a retrospective cohort study

Wolfgang R. Sperr, Michael Kundi, Iván Álvarez‐Twöse et al. · The Lancet Haematology · 2019 · 138 citations · Full text

Life Sciences, Health Sciences, Diagnostic Pathology +6

Masitinib for treatment of severely symptomatic indolent systemic mastocytosis: a randomised, placebo-controlled, phase 3 study

Olivier Lortholary, Marie‐Olivia Chandesris, C. Bulaï Livideanu et al. · The Lancet · 2017 · 122 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +6

Global Classification of Mast Cell Activation Disorders: An ICD-10-CM–Adjusted Proposal of the ECNM-AIM Consortium

Peter Valent, Karin Hartmann, Patrizia Bonadonna et al. · The Journal of Allergy and Clinical Immunology In Practice · 2022 · 87 citations · Full text

Life Sciences, Immunology, Allergy +16